Iridius.ai

ai, Inc.ai, Inc. is focused on providing artificial intelligence solutions tailored for enterprises in regulated sectors.6 mn.Iridius specializes in compliance-driven artificial intelligence solutions tailored for regulated enterprises. The company's core product offering transforms regulatory standards into executable logic, embedding compliance directly within AI workflows. This integration ensures that evidence is generated continuously as systems operate, addressing challenges faced by organizations in regulated environments where safety, regulatory, and clinical tools often lack interoperability. Iridius's solutions are deployed in various sectors, including pharmacovigilance, regulatory submissions, and clinical development, targeting clients who require stringent compliance with GxP (Good Practice) regulations.Iridius's revenue structure is primarily based on subscription models for its compliance-enabling AI solutions, facilitating ongoing partnerships with regulated enterprises. Clients engage with Iridius through direct business-to-business transactions, subscribing to the company's services for compliance automation and workflow management. This subscription model allows organizations to access Iridius's patented technology and tailored support, ensuring continuous compliance readiness. Specific pricing plans for these services are structured to reflect the complexity and scale of the client's operational needs, although detailed pricing information is not disclosed. The company aims to develop new product offerings designed for enhanced compliance automation and workflow efficiency. Furthermore, Iridius intends to enter new geographic markets, focusing on the Asia-Pacific region by 2027, to meet the growing demand for compliance solutions in those areas.

1. Seed

   Mar 31, 2026

   Amount

   $8.6M

   Investors

   Locked